Amgen, Inc. - Strategy and SWOT Report,
- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:Amgen (or 'the company') is a biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. It primarily operates in the US where it is headquartered in Thousand Oaks, California. Amgen employed about 17,900 people as on December 31, 2014.
Reasons to Purchase:Gain understanding of Amgen, Inc. and the factors that influence its strategies Track strategic initiatives of the company and latest corporate news and actions Assess Amgen, Inc. as a prospective partner, vendor or supplierSupport sales activities by understanding your customers' businesses betterStay up to date on Amgen, Inc.’s business structure, strategy and prospects
- Company Snapshot
- Amgen, Inc.: Company Overview
- Amgen, Inc.: Overview and Key Facts
- Amgen, Inc.: Overview
- Amgen, Inc.: Key Facts
- Amgen, Inc.: Key Employees
- Amgen, Inc.: Key Employee Biographies
- Amgen, Inc.: Major Products and Services
- Amgen, Inc.: Company History
- Amgen, Inc.: Management Statement
- Amgen, Inc.: Locations and Subsidiaries
- Amgen, Inc.: Key Competitors
- Amgen, Inc.: Company Analysis
- Amgen, Inc.: Business Description
- Amgen, Inc.: SWOT Analysis
- Amgen, Inc.: SWOT Overview
- Amgen, Inc.: Strengths
- Amgen, Inc.: Weaknesses
- Amgen, Inc.: Opportunities
- Amgen, Inc.: Threats
- Amgen, Inc.: Corporate Financial Deals Activity
- Amgen, Inc.: Financial Deals Overview
- Amgen, Inc.: Targets and Partners
- Amgen, Inc.: Top Deals 2011 - 2015YTD*
- Amgen, Inc.: Advisors
- Amgen, Inc.: Top Legal Advisors
- Amgen, Inc.: Top Financial Advisors
- Amgen, Inc.: Mergers and Acquisitions
- Amgen, Inc.: Partnership
- Amgen, Inc.: Divestments
- Amgen, Inc.: Recent Developments
- Amgen, Inc.: News and Events Summary
- Amgen, Inc.: Business Expansion
- Amgen, Inc.: Contracts
- Amgen, Inc.: Financial Deals
- Amgen, Inc.: Financial Performance
- Amgen, Inc.: Regulatory and Legal Events
- Amgen, Inc.: Research & Development
- Amgen, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- Definitions
- About Market Line
- List of Tables
- Table 1: Amgen, Inc.: Key Facts
- Table 2: Amgen, Inc.: Key Employees
- Table 4: Amgen, Inc.: Key Competitors
- Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Amgen, Inc.: M&A Activity by Geography (TTM*)
- Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
- Table 9: Amgen, Inc.: Targets and Partners
- Table 10: Amgen, Inc.: Top Deals 2011 - 2015YTD*
- Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 13: Amgen, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Table 14: Amgen, Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Table 15: Amgen, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Table 16: Amgen, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
- Table 17: Amgen, Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
- Table 18: Amgen, Inc.: Divestments by Geography (2011 - YTD*2015)
- Table 19: Amgen, Inc.: News and Events Summary
- Table 20: Amgen, Inc.: Business Expansion
- Table 21: Amgen, Inc.: Contracts
- Table 22: Amgen, Inc.: Financial Deals
- Table 23: Amgen, Inc.: Financial Performance
- Table 24: Amgen, Inc.: Regulatory and Legal Events
- Table 25: Amgen, Inc.: Research & Development
- Table 26: Amgen, Inc.: Strategy and Operations
- List of Figures
- Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM*)
- Figure 3: Amgen, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Figure 4: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Figure 6: Amgen, Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Figure 7: Amgen, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Figure 8: Amgen, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
- Figure 9: Amgen, Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
- Figure 10: Amgen, Inc.: Divestments by Geography (2011 - YTD*2015)